Serial liquid biopsies for detection of treatment failure and profiling of resistance mechanisms in KLC1-ALK-rearranged lung cancer

Genetic rearrangements involving the anaplastic lymphoma kinase (ALK) gene confer sensitivity to ALK tyrosine kinase inhibitors (TKIs) and superior outcome in non-small-cell lung cancer (NSCLC). However, clinical courses vary widely, and recent studies suggest that molecular profiling of ALK+ NSCLC...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Dietz, Steffen (VerfasserIn) , Christopoulos, Petros (VerfasserIn) , Gu, Lisa (VerfasserIn) , Volckmar, Anna-Lena (VerfasserIn) , Endris, Volker (VerfasserIn) , Yuan, Zhao (VerfasserIn) , Ogrodnik, Simon (VerfasserIn) , Zemojtel, Tomasz (VerfasserIn) , Heußel, Claus Peter (VerfasserIn) , Schneider, Marc (VerfasserIn) , Meister, Michael (VerfasserIn) , Muley, Thomas (VerfasserIn) , Reck, Martin (VerfasserIn) , Schlesner, Matthias (VerfasserIn) , Thomas, Michael (VerfasserIn) , Stenzinger, Albrecht (VerfasserIn) , Sültmann, Holger (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: November 21, 2019
In: Cold Spring Harbor molecular case studies
Year: 2019, Jahrgang: 5, Heft: 6
ISSN:2373-2873
DOI:10.1101/mcs.a004630
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1101/mcs.a004630
Verlag, lizenzpflichtig, Volltext: http://molecularcasestudies.cshlp.org/content/5/6/a004630
Volltext
Verfasserangaben:Steffen Dietz, Petros Christopoulos, Lisa Gu, Anna-Lena Volckmar, Volker Endris, Zhao Yuan, Simon J. Ogrodnik, Tomasz Zemojtel, Claus-Peter Heussel, Marc A. Schneider, Michael Meister, Thomas Muley, Martin Reck, Matthias Schlesner, Michael Thomas, Albrecht Stenzinger, Holger Sültmann

MARC

LEADER 00000caa a2200000 c 4500
001 1695615301
003 DE-627
005 20250109085222.0
007 cr uuu---uuuuu
008 200422s2019 xx |||||o 00| ||eng c
024 7 |a 10.1101/mcs.a004630  |2 doi 
035 |a (DE-627)1695615301 
035 |a (DE-599)KXP1695615301 
035 |a (OCoLC)1341316249 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Dietz, Steffen  |d 1988-  |e VerfasserIn  |0 (DE-588)1148996575  |0 (DE-627)1009298062  |0 (DE-576)496511556  |4 aut 
245 1 0 |a Serial liquid biopsies for detection of treatment failure and profiling of resistance mechanisms in KLC1-ALK-rearranged lung cancer  |c Steffen Dietz, Petros Christopoulos, Lisa Gu, Anna-Lena Volckmar, Volker Endris, Zhao Yuan, Simon J. Ogrodnik, Tomasz Zemojtel, Claus-Peter Heussel, Marc A. Schneider, Michael Meister, Thomas Muley, Martin Reck, Matthias Schlesner, Michael Thomas, Albrecht Stenzinger, Holger Sültmann 
264 1 |c November 21, 2019 
300 |a 10 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 22.04.2020 
520 |a Genetic rearrangements involving the anaplastic lymphoma kinase (ALK) gene confer sensitivity to ALK tyrosine kinase inhibitors (TKIs) and superior outcome in non-small-cell lung cancer (NSCLC). However, clinical courses vary widely, and recent studies suggest that molecular profiling of ALK+ NSCLC can provide additional predictors of therapy response that could assist further individualization of patient management. As repeated tissue biopsies often pose technical difficulties and significant procedural risk, analysis of tumor constituents circulating in the blood, including ctDNA and various proteins, is increasingly recognized as an alternative method of tumor sampling (“liquid biopsy”). Here, we report the case of a KLC1-ALK-rearranged NSCLC patient responding to crizotinib treatment and demonstrate how analysis of plasma and serum biomarkers can be used to identify the ALK fusion partner and monitor therapy over time. Results of ctDNA sequencing and copy-number alteration profiling as well as serum protein concentrations at various time points during therapy reflected the current remission status and could predict the subsequent clinical course. At the time of disease progression, we identified four distinct secondary mutations in the ALK gene in ctDNA potentially causing treatment failure, accompanied by rising levels of CEA and CYFRA 21-1. Moreover, several copy-number variations were detected at the end of the treatment, including an amplification of a region on Chromosome 12 encompassing the TP53 regulator MDM2. In summary, our findings illustrate the utility of noninvasive longitudinal molecular profiling for assessing remission status, exploring mechanisms of treatment failure, predicting subsequent clinical course, and dissecting dynamics of drug-resistant clones in ALK+ lung cancer. 
650 4 |a lung adenocarcinoma 
700 1 |a Christopoulos, Petros  |d 1977-  |e VerfasserIn  |0 (DE-588)138659702  |0 (DE-627)604886756  |0 (DE-576)308488067  |4 aut 
700 1 |a Gu, Lisa  |d 1996-  |e VerfasserIn  |0 (DE-588)1208775375  |0 (DE-627)1695611195  |4 aut 
700 1 |a Volckmar, Anna-Lena  |d 1984-  |e VerfasserIn  |0 (DE-588)173874916  |0 (DE-627)698776666  |0 (DE-576)134713478  |4 aut 
700 1 |a Endris, Volker  |e VerfasserIn  |0 (DE-588)1063753686  |0 (DE-627)812590961  |0 (DE-576)422898198  |4 aut 
700 1 |a Yuan, Zhao  |d 1988-  |e VerfasserIn  |0 (DE-588)1251323790  |0 (DE-627)1788800192  |4 aut 
700 1 |a Ogrodnik, Simon  |e VerfasserIn  |0 (DE-588)1181809037  |0 (DE-627)1662371349  |4 aut 
700 1 |a Zemojtel, Tomasz  |e VerfasserIn  |4 aut 
700 1 |a Heußel, Claus Peter  |e VerfasserIn  |0 (DE-588)1048631389  |0 (DE-627)780769422  |0 (DE-576)40288146X  |4 aut 
700 1 |a Schneider, Marc  |d 1982-  |e VerfasserIn  |0 (DE-588)140634401  |0 (DE-627)620239948  |0 (DE-576)319208095  |4 aut 
700 1 |a Meister, Michael  |e VerfasserIn  |0 (DE-588)1078792046  |0 (DE-627)839461402  |0 (DE-576)451890108  |4 aut 
700 1 |a Muley, Thomas  |e VerfasserIn  |0 (DE-588)1056885432  |0 (DE-627)794179169  |0 (DE-576)16759284X  |4 aut 
700 1 |a Reck, Martin  |e VerfasserIn  |4 aut 
700 1 |a Schlesner, Matthias  |d 1978-  |e VerfasserIn  |0 (DE-588)138455201  |0 (DE-627)602593867  |0 (DE-576)307654656  |4 aut 
700 1 |a Thomas, Michael  |e VerfasserIn  |0 (DE-588)1054438781  |0 (DE-627)79152213X  |0 (DE-576)41027089X  |4 aut 
700 1 |a Stenzinger, Albrecht  |e VerfasserIn  |0 (DE-588)139606106  |0 (DE-627)703395238  |0 (DE-576)312432755  |4 aut 
700 1 |a Sültmann, Holger  |d 1962-  |e VerfasserIn  |0 (DE-588)172777291  |0 (DE-627)697708144  |0 (DE-576)133633926  |4 aut 
773 0 8 |i Enthalten in  |t Cold Spring Harbor molecular case studies  |d Cold Spring Harbor, NY : CSH Press, 2015  |g 5(2019,6) Artikel-Nummer a004630, 10 Seiten  |h Online-Ressource  |w (DE-627)835893154  |w (DE-600)2835759-0  |w (DE-576)445959398  |x 2373-2873  |7 nnas  |a Serial liquid biopsies for detection of treatment failure and profiling of resistance mechanisms in KLC1-ALK-rearranged lung cancer 
773 1 8 |g volume:5  |g year:2019  |g number:6  |g extent:10  |a Serial liquid biopsies for detection of treatment failure and profiling of resistance mechanisms in KLC1-ALK-rearranged lung cancer 
856 4 0 |u https://doi.org/10.1101/mcs.a004630  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u http://molecularcasestudies.cshlp.org/content/5/6/a004630  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20200422 
994 |a 2019 
998 |g 172777291  |a Sültmann, Holger  |m 172777291:Sültmann, Holger  |d 50000  |e 50000PS172777291  |k 0/50000/  |p 16  |y j 
998 |g 139606106  |a Stenzinger, Albrecht  |m 139606106:Stenzinger, Albrecht  |d 910000  |d 912000  |e 910000PS139606106  |e 912000PS139606106  |k 0/910000/  |k 1/910000/912000/  |p 15 
998 |g 1054438781  |a Thomas, Michael  |m 1054438781:Thomas, Michael  |d 910000  |d 950000  |d 950900  |d 50000  |e 910000PT1054438781  |e 950000PT1054438781  |e 950900PT1054438781  |e 50000PT1054438781  |k 0/910000/  |k 1/910000/950000/  |k 2/910000/950000/950900/  |k 0/50000/  |p 14 
998 |g 138455201  |a Schlesner, Matthias  |m 138455201:Schlesner, Matthias  |d 140000  |e 140000PS138455201  |k 0/140000/  |p 13 
998 |g 1056885432  |a Muley, Thomas  |m 1056885432:Muley, Thomas  |d 910000  |d 950000  |d 950900  |e 910000PM1056885432  |e 950000PM1056885432  |e 950900PM1056885432  |k 0/910000/  |k 1/910000/950000/  |k 2/910000/950000/950900/  |p 12 
998 |g 1078792046  |a Meister, Michael  |m 1078792046:Meister, Michael  |d 910000  |d 950000  |d 950900  |e 910000PM1078792046  |e 950000PM1078792046  |e 950900PM1078792046  |k 0/910000/  |k 1/910000/950000/  |k 2/910000/950000/950900/  |p 11 
998 |g 140634401  |a Schneider, Marc  |m 140634401:Schneider, Marc  |d 910000  |d 950000  |d 950900  |e 910000PS140634401  |e 950000PS140634401  |e 950900PS140634401  |k 0/910000/  |k 1/910000/950000/  |k 2/910000/950000/950900/  |p 10 
998 |g 1048631389  |a Heußel, Claus Peter  |m 1048631389:Heußel, Claus Peter  |d 910000  |d 950000  |d 950900  |d 50000  |e 910000PH1048631389  |e 950000PH1048631389  |e 950900PH1048631389  |e 50000PH1048631389  |k 0/910000/  |k 1/910000/950000/  |k 2/910000/950000/950900/  |k 0/50000/  |p 9 
998 |g 1181809037  |a Ogrodnik, Simon  |m 1181809037:Ogrodnik, Simon  |p 7 
998 |g 1251323790  |a Yuan, Zhao  |m 1251323790:Yuan, Zhao  |d 140000  |e 140000PY1251323790  |k 0/140000/  |p 6 
998 |g 1063753686  |a Endris, Volker  |m 1063753686:Endris, Volker  |d 910000  |d 912000  |e 910000PE1063753686  |e 912000PE1063753686  |k 0/910000/  |k 1/910000/912000/  |p 5 
998 |g 173874916  |a Volckmar, Anna-Lena  |m 173874916:Volckmar, Anna-Lena  |d 910000  |d 912000  |e 910000PV173874916  |e 912000PV173874916  |k 0/910000/  |k 1/910000/912000/  |p 4 
998 |g 1208775375  |a Gu, Lisa  |m 1208775375:Gu, Lisa  |d 50000  |e 50000PG1208775375  |k 0/50000/  |p 3 
998 |g 138659702  |a Christopoulos, Petros  |m 138659702:Christopoulos, Petros  |d 50000  |d 910000  |d 950000  |d 950900  |e 50000PC138659702  |e 910000PC138659702  |e 950000PC138659702  |e 950900PC138659702  |k 0/50000/  |k 0/910000/  |k 1/910000/950000/  |k 2/910000/950000/950900/  |p 2 
998 |g 1148996575  |a Dietz, Steffen  |m 1148996575:Dietz, Steffen  |p 1  |x j 
999 |a KXP-PPN1695615301  |e 3629790011 
BIB |a Y 
SER |a journal 
JSO |a {"physDesc":[{"extent":"10 S."}],"recId":"1695615301","relHost":[{"type":{"media":"Online-Ressource","bibl":"periodical"},"corporate":[{"role":"isb","display":"Cold Spring Harbor Laboratory"}],"note":["Gesehen am 26.05.2020"],"physDesc":[{"extent":"Online-Ressource"}],"recId":"835893154","title":[{"title":"Cold Spring Harbor molecular case studies","title_sort":"Cold Spring Harbor molecular case studies"}],"disp":"Serial liquid biopsies for detection of treatment failure and profiling of resistance mechanisms in KLC1-ALK-rearranged lung cancerCold Spring Harbor molecular case studies","name":{"displayForm":["Cold Spring Harbor Laboratory"]},"id":{"issn":["2373-2873"],"eki":["835893154"],"zdb":["2835759-0"]},"part":{"year":"2019","issue":"6","text":"5(2019,6) Artikel-Nummer a004630, 10 Seiten","extent":"10","volume":"5"},"origin":[{"dateIssuedDisp":"2015-","publisher":"CSH Press","publisherPlace":"Cold Spring Harbor, NY","dateIssuedKey":"2015"}],"pubHistory":["1.2015 -"],"language":["eng"]}],"language":["eng"],"note":["Gesehen am 22.04.2020"],"id":{"doi":["10.1101/mcs.a004630"],"eki":["1695615301"]},"person":[{"role":"aut","display":"Dietz, Steffen","family":"Dietz","given":"Steffen"},{"family":"Christopoulos","display":"Christopoulos, Petros","role":"aut","given":"Petros"},{"family":"Gu","role":"aut","display":"Gu, Lisa","given":"Lisa"},{"family":"Volckmar","role":"aut","display":"Volckmar, Anna-Lena","given":"Anna-Lena"},{"given":"Volker","role":"aut","display":"Endris, Volker","family":"Endris"},{"given":"Zhao","family":"Yuan","display":"Yuan, Zhao","role":"aut"},{"family":"Ogrodnik","role":"aut","display":"Ogrodnik, Simon","given":"Simon"},{"display":"Zemojtel, Tomasz","role":"aut","family":"Zemojtel","given":"Tomasz"},{"given":"Claus Peter","family":"Heußel","display":"Heußel, Claus Peter","role":"aut"},{"role":"aut","display":"Schneider, Marc","family":"Schneider","given":"Marc"},{"given":"Michael","role":"aut","display":"Meister, Michael","family":"Meister"},{"given":"Thomas","display":"Muley, Thomas","role":"aut","family":"Muley"},{"given":"Martin","family":"Reck","display":"Reck, Martin","role":"aut"},{"role":"aut","display":"Schlesner, Matthias","family":"Schlesner","given":"Matthias"},{"given":"Michael","family":"Thomas","display":"Thomas, Michael","role":"aut"},{"given":"Albrecht","family":"Stenzinger","display":"Stenzinger, Albrecht","role":"aut"},{"role":"aut","display":"Sültmann, Holger","family":"Sültmann","given":"Holger"}],"origin":[{"dateIssuedKey":"2019","dateIssuedDisp":"November 21, 2019"}],"title":[{"title_sort":"Serial liquid biopsies for detection of treatment failure and profiling of resistance mechanisms in KLC1-ALK-rearranged lung cancer","title":"Serial liquid biopsies for detection of treatment failure and profiling of resistance mechanisms in KLC1-ALK-rearranged lung cancer"}],"name":{"displayForm":["Steffen Dietz, Petros Christopoulos, Lisa Gu, Anna-Lena Volckmar, Volker Endris, Zhao Yuan, Simon J. Ogrodnik, Tomasz Zemojtel, Claus-Peter Heussel, Marc A. Schneider, Michael Meister, Thomas Muley, Martin Reck, Matthias Schlesner, Michael Thomas, Albrecht Stenzinger, Holger Sültmann"]},"type":{"media":"Online-Ressource","bibl":"article-journal"}} 
SRT |a DIETZSTEFFSERIALLIQU2120